Bibliography 2


Arom et al. Intramyocardial Angiogenic Cell Precursor Injection for Cardiomyopathy. Asian Cardiovasc Thorac Ann 2008;16:143-148


Chaithiraphan et al. Transcoronary Injection of Angiogenic Cell Precursors an Autologous Stem Cell in Ischemic Cardiomyopathy: A Clinical Study of 106 Cases. ASEAN HEART JOURNAL 2009; 17: 13-22.


Mutirangura et al. Enhancing limb salvage by non-mobilized peripheral blood angiogenic cell precursors therapy in patients with critical limb ischemia. Journal of the Medical Association of Thailand; 2009 Mar. 92(3):320-7.

Misskey et al. Autologous Stem Cell Treatment for CLI Patients with no Revascularization Options: An Update of the Hemostemix ACP-01 Trial with 4.5 Year Follow-up. Poster, 41st Meeting of Vascular Surgeons, Kelowna, BC.


Porat et al. Isolation of an adult blood-derived progenitor cell population capable of differentiation into    angiogenic, myocardial and neural lineages. British Journal of Haematology, 135, 703–714

Schubart et al. Safety and outcomes analysis: transcatheter implantation of autologous angiogenic cell precursors for the treatment of cardiomyopathy. Stem Cell Research & Therapy, 2023 14:308. 

Sun et al. Human angiogenic cell precursors restore function in the infarcted rat heart: A comparison of cell delivery routes.  European Journal of Heart Failure 10 (2008) 525–533.


Szabo et al. Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short and long-term follow-up. CytoTherapy, 2013 Oct. 15 (10).

Trekusol et al. Treatment of Patients with Severe Angina Pectoris Using Intracoronarily Injected Autologous Blood-Borne Angiogenic Cell Precursors. Circulation, 2006;114:II 786.